课题基金 / 基金详情

Age-environment interaction influencing skeletal muscle satellite cell function

Age-environment interaction influencing skeletal muscle satellite cell function
年龄-环境相互作用影响骨骼肌卫星细胞功能
批准号:
8333955
负责人:
Simon James Lees
金额:
$5.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2014-08-31

项目摘要

项目成果

Simon James Lees的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):骨骼肌减少症是一种与年龄相关的骨骼肌质量和力量的损失。最近的估计表明,多达45%的美国老年人患有肌肉减少症。骨骼肌减少症的严重临床结果包括身体虚弱导致失去独立生活,养老院使用率增加以及死亡率逐渐增加。造成肌肉减少症的一个因素是衰老的骨骼肌在一次萎缩后再生、肥大和再生长的能力下降。在骨骼肌中,负责骨骼肌生长和修复的常驻干细胞被称为卫星细胞。最近的证据表明,与年龄相关的卫星细胞功能丧失是导致再生潜力丧失和老年骨骼肌萎缩和纤维化增加的主要因素。长期目标是更好地了解调节卫星细胞功能的机制,以促进治疗策略的发展。卫星小区的功能很大程度上取决于周围的环境。然而,我们也知道,与从年轻肌肉中分离出来的卫星细胞相比,来自老年骨骼肌的卫星细胞对环境的反应不同。关键的潜在问题是卫星细胞/环境相互作用如何导致衰老过程中骨骼肌再生/肥大/再生受损?衰老与慢性低度全身性炎症有关,这种情况可以通过循环中某些细胞因子(包括TNF-1、IL-1和IL-6)水平增加2至3倍来确定。有趣的是,已知TNF-1和IL-12都能引起IL-6的表达,而IL-6具有促纤维化功能。重要的是,与年轻肌肉相比,老年骨骼肌中的卫星细胞表现出肌原性-纤维性谱系转变和损伤再生反应受损。具体目标#1将确定il -12诱导IL-6表达的年龄依赖性差异的机制。具体而言,Specific Aim #1将确定IL-6表达的转录调节增加,mRNA稳定性的贡献,以及内源性IL- 12诱导的TNF-1表达对老年骨骼肌分离的卫星细胞中IL-6表达增加的贡献。此外,将确定IL-12处理的卫星细胞中纤维化基因表达的年龄相关差异。这一发现将对确定衰老过程中卫星细胞功能减弱的潜在机制产生影响。特异性目的2将确定挫伤后增加IL-12治疗是否会增加体内IL-6表达和骨骼肌纤维化。此外,特异性Aim #2将测试抗il -12治疗(重组il -1受体拮抗剂)是否能降低IL-6表达和损伤后骨骼肌纤维化。该提案的总体目标是确定IL-12、TNF-1和IL-6的增加是否在损伤后卫星细胞功能下降和骨骼肌纤维化增加中起作用。这些发现将对未来的干预措施产生影响,旨在增加我们衰老和身体虚弱人群的骨骼肌质量和力量。
英文摘要
DESCRIPTION (provided by applicant): Sarcopenia is an age-associated loss of skeletal muscle mass and strength. Recent estimates suggest that as much as 45% of the older U.S. population suffers from sarcopenia. Grave clinical outcomes of sarcopenia include the onset of physical frailty leading to the loss of independent living, increased nursing home utilization, and progressive increase in mortality. One contributing factor to sarcopenia is the diminished capacity for aged skeletal muscle to regenerate, hypertrophy, and regrow after a bout of atrophy. In skeletal muscle, the resident stem cells responsible for skeletal muscle growth and repair are termed satellite cells. Recent evidence suggests that an age-associated loss of satellite cell functionality is the primary factor responsible for the loss of regenerative potential and increased atrophy and fibrosis of aged skeletal muscle. The long-term objective is to gain a better understanding of mechanisms regulating satellite cell function in order to facilitate the development of therapeutic strategies. Satellite cell function is largely dictated by the surrounding environment. However, it is also known that satellite cells from aged skeletal muscle respond to the environment differently, compared to satellite cells isolated from young muscle. The key underlying question is how do the satellite cell/environment interactions contribute to impaired skeletal muscle regeneration/hypertrophy/regrowth in aging? Aging is associated with chronic low-grade systemic inflammation, which is a condition that is identified by a ~2- to 3-fold increase in circulating levels of certain cytokines including TNF-1, IL-1, and IL-6. Interestingly, both TNF-1 and IL-12 are known to cause IL-6 expression, which has pro-fibrotic function. Importantly, satellite cells in aged skeletal muscle exhibit a myogenic-fibrogenic lineage transition and impaired regenerative response to injury, compared to young muscle. Specific aim #1 will determine the mechanisms responsible for the observed age-dependent differences in IL-12-induced IL-6 expression. Specifically, Specific Aim #1 will determine the contribution of increased transcriptional regulation of IL-6 expression, mRNA stability, and the contribution of endogenous IL- 12-induced TNF-1 expression to increased IL-6 expression in satellite cells isolated from aged skeletal muscle. Moreover, age-associated differences in fibrotic gene expression in IL-12 treated satellite cells will be determined. The findings will have implications for identifying underlying mechanisms responsible for diminished satellite cell function in aging. Specific Aim #2 will determine whether increased IL-12 treatment after contusion injury increases IL-6 expression and skeletal muscle fibrosis in vivo. Moreover, Specific Aim #2 will test whether treatment with an anti-IL-12 treatment (recombinant IL-1-receptor antagonist) can decrease IL-6 expression and skeletal muscle fibrosis after injury. The overall goal of the proposal is to determine whether increased IL-12, TNF-1, and IL-6 play a role in decreased satellite cell function and increased skeletal muscle fibrosis after injury. These findings will have implications for future interventions aimed at increasing skeletal muscle mass and strength in our aging and physically frail populations.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4172/2155-6156.s13-003
发表时间: 2013-05-24
期刊: Journal of diabetes & metabolism
影响因子: --
作者: [Sarvas JL, Khaper N, Lees SJ]
通讯作者: Lees SJ
DOI: 10.1371/journal.pone.0092363
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Otis JS, Niccoli S, Hawdon N, Sarvas JL, Frye MA, Chicco AJ, Lees SJ]
通讯作者: Lees SJ
Age-environment interaction influencing skeletal muscle satellite cell function
  • 批准号:
    8047095
  • 项目类别:
  • 资助金额:
    $6.03万
  • 财政年份:
    2011
  • 负责人:
    Simon James Lees
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: